Want to join the conversation?
Biopharmaceutical company $AMGN said the US FDA has issued a Complete Response Letter for the NDA for Parsabiv for treating secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis. Company is reviewing the letter, and anticipates a post-action meeting with the FDA later this year to discuss the response.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.